What Gwen Ifill's Story Can Help Us Understand About Uterine (Endometrial) Cancer

What was reported

Gwen Ifill co-anchored the PBS NewsHour and moderated Washington Week. NPR noted that when she took over Washington Week in Review in 1999 she became the first African American woman to host a major political television talk show. She covered seven presidential campaigns and moderated two vice-presidential debates.

PBS announced on 14 November 2016 that she had died that afternoon, at 61, after several months of cancer treatment, surrounded by family and friends. Two days later, PBS NewsHour named the disease as endometrial cancer in a broadcast segment about gynecological cancers.

That is the public record. We do not speculate about any detail of her care beyond it.

Two different cancers, one organ

NCI divides uterine cancer into two. Endometrial cancer, which is the common one, begins in the endometrium, the inner lining of the uterus. Uterine sarcoma, which is rare, begins in the muscle or supporting tissue and behaves more aggressively.

They are not interchangeable, and the treatment plans differ. When someone says "uterine cancer," the first useful question is which of the two.

The test that does not catch it

This is the part most people get wrong, and it is worth stating plainly.

NCI is explicit: because endometrial cancer begins inside the uterus, it does not usually show up on a Pap test. A Pap test samples the cervix. It is an excellent tool for cervical cancer and a poor one for this.

There is no routine screening test for endometrial cancer in women at average risk. Diagnosis depends on someone noticing bleeding and acting on it.

NCI lists the procedures used when there is a suspicion. An endometrial biopsy passes a thin flexible tube through the cervix to scrape a small tissue sample. Dilatation and curettage, or D&C, widens the cervix and uses a spoon-shaped curette to take a larger sample. Hysteroscopy passes a lighted scope into the uterus to look directly. A transvaginal ultrasound, using a probe inserted into the vagina, is often the first imaging step. Our guide to how cancer is diagnosed sets out the general order of things.

Who is more likely to get it

NCI lists the main risk factors. Estrogen without progesterone is the thread running through most of them:

• Estrogen-only hormone replacement therapy after menopause
• Taking tamoxifen to prevent or treat breast cancer
• Obesity, metabolic syndrome, or type 2 diabetes
• Never having given birth, starting periods early, or reaching menopause late
• Polycystic ovary syndrome
• Endometrial hyperplasia, a thickening of the uterine lining
• A mother, sister or daughter with endometrial cancer
• Lynch syndrome, an inherited condition that raises risk of several cancers

Older age is the main risk factor for most cancers, and this one is no exception. Having a risk factor does not mean a person will get cancer, and having none does not mean they will not.

The numbers

The American Cancer Society estimates 68,270 new US uterine cancer diagnoses and 14,450 deaths in 2026, and SEER republishes that pair. Five-year relative survival across all stages, for cases diagnosed in 2016 to 2022, is 80.9%.

Stage separates that sharply, across the same 2016 to 2022 group. Localized disease, still confined to the uterus, carries 94.9% five-year relative survival. Regional disease carries 70.1%. Distant disease carries 19.9%. Sixty-seven percent of US cases are found while localized, which is high, and that is almost entirely because bleeding is noticeable and prompts a visit.

These are group figures across many people and past years. They do not describe any one person. Our page on uterine cancer has more on types and staging.

When to get checked

NCI lists these as reasons to check with a doctor. The first one is the one that saves lives:

• Any vaginal bleeding after menopause. Not heavy bleeding. Any bleeding, once, even spotting.
• Vaginal bleeding or discharge not related to a period
• Difficult or painful urination
• Pain during sex
• Pain in the pelvic area

Postmenopausal bleeding is the single most useful symptom in gynecologic oncology. Most causes turn out to be harmless. It should still be checked within weeks, not months. Our page on cancer symptoms covers what makes a symptom worth escalating.

What this does not mean

• PBS reported the disease. Nothing about her stage, treatment or timeline was made public, and this page does not infer any of it.
• A normal Pap test says nothing about the endometrium. Do not use one as reassurance about uterine bleeding.
• Risk factors describe populations. Many people with several never develop endometrial cancer, and some with none do.
• The 80.9% figure is an all-stages average from past years. It is not a forecast for anyone reading this.

Sources

• PBS NewsHour, PBS NewsHour Co-anchor Gwen Ifill Dies at 61 — https://www.pbs.org/newshour/press-releases/pbs-newshour-co-anchor-gwen-ifill-dies-61
• PBS NewsHour, The challenges of fighting gynecological cancers — https://www.pbs.org/newshour/show/challenges-fighting-gynecological-cancers
• NPR, Gwen Ifill, Host Of 'Washington Week' And 'PBS NewsHour,' Dies — https://www.npr.org/sections/thetwo-way/2016/11/14/502031518/gwen-ifill-host-of-washington-week-pbs-newshour-dies
• NCI PDQ, Endometrial Cancer Treatment (Patient Version) — https://www.cancer.gov/types/uterine/patient/endometrial-treatment-pdq
• SEER Cancer Stat Facts, Uterine Cancer — https://seer.cancer.gov/statfacts/html/corp.html

How this article was prepared

An AI-assisted editorial system helped prepare this page. No named medical reviewer has reviewed it unless one is listed.

The National Cancer Information Foundation publishes Cancer Explained. This page is for learning. It is not medical advice and does not suggest a test or treatment.

See an error, old source, or unclear wording? Tell us.